Testing a new imaging scan for amyloid heart disease

This trial is testing a new imaging technology called [18F]FT8 PET/CT that may help doctors better detect and measure amyloid protein buildup in the heart and other organs. The study involves healthy volunteers and people with amyloidosis receiving this special scan to see how well it works and how safe it is.

Amyloidosis is a serious condition where abnormal proteins build up in organs like the heart, but current imaging methods may not always detect this buildup clearly. This trial is testing whether the new scan can provide better, clearer images to help doctors diagnose and monitor this disease.